Effect of Bee Pollen Kelulut Bees on HBA1C in Type 2 Diabetes Mellitus Patients

Abstract

Bee pollen has been used for generations to treat various diseases, including diabetes mellitus, because it inhibits alpha glucosidase enzyme. Two major problems suffered by patients with type 2 Diabetes Mellitus (DM) are linked to insulin resistance and impaired insulin secretion. They often occur in patients aged above 30 years and obese patients. High blood glucose and other complications, including increased HBA1C, are some of the risks faced by people with type 2 diabetes mellitus. This study aimed to reveal the efficacy of bee pollen in lowering the HBA1C levels of patients with type 2 DM. Subjects were gave bee pollen kelulut bees to the intervention group, twice a day in the morning during 4 weeks. This study was quasy experimental research. It involved 30 patients who were divided into the intervention group and the control group. Data were analysis determined the differences in the control and intervention groups using the Mann Whitney test. The result of pre- and post-group was p value=0.001(<0.05), meaning that there was a significant difference in median cholesterol levels, while the result difference of the two groups was p value=0.033 (<0.05), implying there was a significant difference in HBA1C levels of the two groups. Bee pollen has been shown to lower HBA1C and have a potential as a non-pharmacological treatment in patients with type 2 DM.